University of Virginia 6 mouse cancer cell DIAQuantitative Proteomics

Metware Biotechnology Inc has been awarded a contract by the University of Virginia with an award date of July 21, 2026, for a cumulative contract value of $2,550.00. The contracting organization, the University of Virginia, is located in Virginia. The contract encompasses the delivery of specialized research materials and services related to quantitative proteomics analysis.

Under this contract, Metware Biotechnology Inc will deliver six mouse cancer cell samples for quantitative proteomics analysis to Xiaoliang Wang at the University of Virginia. The line item specifies a unit price of $2,550.00 for this deliverable, which is measured as a single unit. Quantitative proteomics is an analytical technique used to identify and quantify proteins in biological samples, which is critical for cancer research applications. This contract represents a focused research support engagement between the prime contractor and the University of Virginia's research operations.